AbbVie : ABBV

All AbbVie Articles

616 Articles

Chris Lange | Jan 12, 2022 at 3:08 PM EST

Wednesday Afternoon Analyst Upgrades and Downgrades: AbbVie, Biogen, DoorDash, Kratos Defense, PayPal and More

Wednesday afternoon's top analyst upgrades and downgrades included AbbVie, Biogen, DoorDash, Kratos Defense, PayPal and more.

Lee Jackson | Dec 29, 2021 at 7:26 AM EST

5 High-Yielding Dividend Aristocrats Are ‘Strong Buy’ Stock Ideas for 2022

These five Dividend Aristocrats are in sectors that have underperformed in 2021 or are solid plays as investors continue to…

Chris Lange | Dec 9, 2021 at 11:50 AM EST

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Thursday afternoon's top analyst upgrades and downgrades included AbbVie, Allstate, Amgen, Occidental Petroleum, Pfizer, SunPower, Twilio and Yum! Brands.

Lee Jackson | Dec 9, 2021 at 7:35 AM EST

Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends

Shares of five top established and mature biotechnology and pharmaceutical companies have been hit hard and are offering some of…

Lee Jackson | Dec 1, 2021 at 7:28 AM EST

5 Health Care Dividend Aristocrats to Buy for 2022 as Yields Plunge Once Again

Now is the time to reduce risk and more to safer ideas. Top-quality health care stocks may be the way…

Lee Jackson | Nov 23, 2021 at 8:52 AM EST

Tuesday’s Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Comcast, GE, Micron, Nvidia, Salesforce, Zoom Video and More

Tuesday's top analyst upgrades and downgrades included AbbVie, Altice USA, Amazon.com, Comcast, General Electric, Kimco Realty, Micron Technology, Nvidia, Salesforce.com,…

Lee Jackson | Nov 18, 2021 at 7:35 AM EST

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

Health care is poised to benefit from a shift toward more defensive sectors. These five stocks have strong balance sheets,…

Lee Jackson | Nov 1, 2021 at 7:35 AM EDT

5 Big Dividend Biotech and Pharmaceutical Stocks Have Strong Upside Potential

In this massively overbought market, health care stocks could benefit from a shift toward more defensive sectors. These five offer…

Lee Jackson | Oct 25, 2021 at 10:40 AM EDT

5 Buy-Rated Blue Chips Are Raising Their Dividends This Week

These five top companies are expected to lift the dividends they pay to shareholders, and their stocks are rated Buy…

Lee Jackson | Sep 22, 2021 at 7:24 AM EDT

Hedge Funds Dump Stocks: Move to These 5 Big Dividend Winners Now

Hedge fund managers are getting more defensive, and it is probably high-time individual investors do as well. These five stocks…

Lee Jackson | Sep 3, 2021 at 7:06 AM EDT

Why 5 of the Highest-Yielding Dividend Aristocrats May Be the Safest Bet for Rest of 2021

With a bloated and overbought market, and the lack of a 5% correction in almost a year, shifting to some…

Paul Ausick | Aug 8, 2021 at 7:24 AM EDT

5 Top Stocks Analysts Want You to Buy Now

24/7 Wall St. reviews dozens of analyst research reports each day of the week with a goal of finding new…

Lee Jackson | Aug 4, 2021 at 7:35 AM EDT

4 Big Pharma Dividend Stocks to Buy as Yields Near 2021 Lows

These four big pharmaceutical stocks are rated Buy by top Wall Street firms and look like very good ideas for…

Lee Jackson | Jul 27, 2021 at 8:50 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, American Airlines, Chipotle, JD.com, Pfizer, Starbucks and More

Tuesday's top analyst upgrades and downgrades included AbbVie, Alibaba, American Airlines, AT&T, Chipotle Mexican Grill, JD.com, Kimberly-Clark, Pfizer, Starbucks and…

Lee Jackson | Jul 27, 2021 at 7:36 AM EDT

S&P 500 Dividend Yield Lowest in 20 Years: 5 Blue Chips to Buy Now With Huge Dividends

With bond yields remaining at generational lows, and the prospect of them going meaningfully higher in the near term seemingly…

1 … 12 13 14 15 16 … 42

AbbVie : ABBV

All AbbVie Articles

Wednesday Afternoon Analyst Upgrades and Downgrades: AbbVie, Biogen, DoorDash, Kratos Defense, PayPal and More

5 High-Yielding Dividend Aristocrats Are ‘Strong Buy’ Stock Ideas for 2022

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends

5 Health Care Dividend Aristocrats to Buy for 2022 as Yields Plunge Once Again

Tuesday’s Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Comcast, GE, Micron, Nvidia, Salesforce, Zoom Video and More

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

5 Big Dividend Biotech and Pharmaceutical Stocks Have Strong Upside Potential

5 Buy-Rated Blue Chips Are Raising Their Dividends This Week

Hedge Funds Dump Stocks: Move to These 5 Big Dividend Winners Now

Why 5 of the Highest-Yielding Dividend Aristocrats May Be the Safest Bet for Rest of 2021

5 Top Stocks Analysts Want You to Buy Now

4 Big Pharma Dividend Stocks to Buy as Yields Near 2021 Lows

Tuesday’s Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, American Airlines, Chipotle, JD.com, Pfizer, Starbucks and More

S&P 500 Dividend Yield Lowest in 20 Years: 5 Blue Chips to Buy Now With Huge Dividends

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

SpaceX Just Erased $1 Trillion in Value. Here’s Why the Worst Could Be Yet to Come.

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

AbbVie : ABBV

All AbbVie Articles

Wednesday Afternoon Analyst Upgrades and Downgrades: AbbVie, Biogen, DoorDash, Kratos Defense, PayPal and More

5 High-Yielding Dividend Aristocrats Are ‘Strong Buy’ Stock Ideas for 2022

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends

5 Health Care Dividend Aristocrats to Buy for 2022 as Yields Plunge Once Again

Tuesday’s Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Comcast, GE, Micron, Nvidia, Salesforce, Zoom Video and More

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

5 Big Dividend Biotech and Pharmaceutical Stocks Have Strong Upside Potential

5 Buy-Rated Blue Chips Are Raising Their Dividends This Week

Hedge Funds Dump Stocks: Move to These 5 Big Dividend Winners Now

Why 5 of the Highest-Yielding Dividend Aristocrats May Be the Safest Bet for Rest of 2021

5 Top Stocks Analysts Want You to Buy Now

4 Big Pharma Dividend Stocks to Buy as Yields Near 2021 Lows

Tuesday’s Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, American Airlines, Chipotle, JD.com, Pfizer, Starbucks and More

S&P 500 Dividend Yield Lowest in 20 Years: 5 Blue Chips to Buy Now With Huge Dividends

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

SpaceX Just Erased $1 Trillion in Value. Here’s Why the Worst Could Be Yet to Come.

Featured Reads

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account